Nicolas Wiernsperger

ADIR Association — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index4.7kcitations130works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolism, Diabetes, and Cancer(40), Advanced Glycation End Products research(31), Pancreatic function and diabetes(19), Diet and metabolism studies(14), Retinal Diseases and Treatments(11)

Publications130 total

Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
Diabetes & Metabolism·2022· 28 citedOpen Access
A comment on metformin and <scp>COVID</scp> ‐19 with regard to “Metformin use is associated with a decrease in the risk of hospitalization and mortality in <scp>COVID</scp> ‐19 patients with diabetes: A population‐based study in Lombardy”
Diabetes Obesity and Metabolism·2022· 2 citedOpen Access
La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
Médecine des Maladies Métaboliques·2021Open Access
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
2021· 18 cited
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
Diabetes & Metabolism·2020· 93 citedOpen Access
Untitled
Journal of Diabetes Metabolic Disorders & Control·2018Open Access
New concepts in microvascular function and metabolic diseases: importance of cephalic phase of insulin response
Journal of Diabetes Metabolic Disorders & Control·2018· 1 citedOpen Access
Evidences that insulin resistance, core of cardiometabolic diseases, is the primary therapeutic target
Journal of Diabetes & Metabolism·2017
From pathophysiology to therapy: Why herbal medicine, when and for what?
Journal of Diabetes & Metabolism·2017
Metformin‐associated lactic acidosis ( <scp>MALA</scp> ): <scp>M</scp> oving towards a new paradigm
Diabetes Obesity and Metabolism·2017· 127 cited
The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state
PLoS ONE·2017· 19 citedOpen Access
Treatment Strategies for Fatty Liver Diseases
Reviews on Recent Clinical Trials·2015· 7 cited
Metformin as a cellular protector; a synoptic view of modern evidences.
PubMed·2015· 14 citedOpen Access
Microcirculation
Elsevier eBooks·2014
List of Contributors
Elsevier eBooks·2014
Hepatic function and the cardiometabolic syndrome
Diabetes Metabolic Syndrome and Obesity·2013· 23 citedOpen Access
Microvascular Diseases: Is A New Era Coming?
Cardiovascular & Hematological Agents in Medicinal Chemistry·2012· 28 cited
Novel findings in the cephalic phase of digestion: A role for microcirculation?
Physiology & Behavior·2011· 26 cited
Metformin Causes Nitric Oxide–mediated Dilatation in a Shorter Time Than Insulin in the Iliac Artery of the Anesthetized Pig
Journal of Cardiovascular Pharmacology·2011· 23 cited
Biological Clocks: Nature, Organization and Interactions
Journal of Endocrinology and Metabolism·2011
page 1 of 7Next →

Frequent Co-authors

Michel Lagarde(14), Daniel Ruggiero(6), Marc Lecomte(5), Samer El Bawab(5), Bruno Guigas(4), Xavier Leverve(4), J. R. Rapin(4), Eliete Bouskela(4), Dominique Détaille(3), Daniel Ruggiero-Lopez(3), Christophe Paget(3), Jean‐Daniel Lalau(3), Lysiane Troncy(3), Elodie Masson(3), Cécile Batandier(2), Éric Fontaine(2), Jean‐Claude Mamputu(2), Geneviève Renier(2), Pierre Faure(2), S. Halimi(2)